vs
bioAffinity Technologies, Inc.（BIAF）与OmniAb, Inc.（OABI）财务数据对比。点击上方公司名可切换其他公司
OmniAb, Inc.的季度营收约是bioAffinity Technologies, Inc.的5.3倍（$8.4M vs $1.6M）。OmniAb, Inc.净利率更高（-169.3% vs -197.0%，领先27.7%）。OmniAb, Inc.同比增速更快（-22.5% vs -27.8%）。bioAffinity Technologies, Inc.自由现金流更多（$-2.6M vs $-5.7M）。过去两年OmniAb, Inc.的营收复合增速更高（48.4% vs -18.6%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
OmniAb, Inc.是一家跨国生物技术企业，拥有专利转基因动物平台及全流程抗体发现解决方案，与全球制药和生物科技公司合作，加速肿瘤、自身免疫病等刚需医疗领域的全人源治疗抗体开发。
BIAF vs OABI — 直观对比
营收规模更大
OABI
是对方的5.3倍
$1.6M
营收增速更快
OABI
高出5.4%
-27.8%
净利率更高
OABI
高出27.7%
-197.0%
自由现金流更多
BIAF
多$3.1M
$-5.7M
两年增速更快
OABI
近两年复合增速
-18.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $8.4M |
| 净利润 | $-3.1M | $-14.2M |
| 毛利率 | — | — |
| 营业利润率 | -196.9% | -188.2% |
| 净利率 | -197.0% | -169.3% |
| 营收同比 | -27.8% | -22.5% |
| 净利润同比 | -5.7% | -8.5% |
| 每股收益（稀释后） | $-3.59 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFOABI
| Q4 25 | $1.6M | $8.4M | ||
| Q3 25 | $1.4M | $2.2M | ||
| Q2 25 | $1.3M | $3.9M | ||
| Q1 25 | $1.9M | $4.2M | ||
| Q4 24 | $2.2M | $10.8M | ||
| Q3 24 | $2.4M | $4.2M | ||
| Q2 24 | $2.4M | $7.6M | ||
| Q1 24 | $2.4M | $3.8M |
净利润BIAFOABI
| Q4 25 | $-3.1M | $-14.2M | ||
| Q3 25 | $-5.1M | $-16.5M | ||
| Q2 25 | $-4.1M | $-15.9M | ||
| Q1 25 | $-2.7M | $-18.2M | ||
| Q4 24 | $-3.0M | $-13.1M | ||
| Q3 24 | $-2.0M | $-16.4M | ||
| Q2 24 | $-2.1M | $-13.6M | ||
| Q1 24 | $-2.0M | $-19.0M |
营业利润率BIAFOABI
| Q4 25 | -196.9% | -188.2% | ||
| Q3 25 | -158.6% | -810.2% | ||
| Q2 25 | -198.2% | -416.2% | ||
| Q1 25 | -141.7% | -453.6% | ||
| Q4 24 | -133.5% | -147.0% | ||
| Q3 24 | -84.0% | -473.7% | ||
| Q2 24 | -87.1% | -214.1% | ||
| Q1 24 | -80.8% | -593.3% |
净利率BIAFOABI
| Q4 25 | -197.0% | -169.3% | ||
| Q3 25 | -349.3% | -738.1% | ||
| Q2 25 | -319.9% | -407.4% | ||
| Q1 25 | -143.5% | -438.1% | ||
| Q4 24 | -134.4% | -121.0% | ||
| Q3 24 | -85.1% | -392.4% | ||
| Q2 24 | -88.0% | -179.0% | ||
| Q1 24 | -81.5% | -498.8% |
每股收益（稀释后）BIAFOABI
| Q4 25 | $-3.59 | $-0.11 | ||
| Q3 25 | $-4.74 | $-0.14 | ||
| Q2 25 | $-0.17 | $-0.15 | ||
| Q1 25 | $-0.16 | $-0.17 | ||
| Q4 24 | $-17.27 | $-0.13 | ||
| Q3 24 | $-4.84 | $-0.16 | ||
| Q2 24 | $-0.19 | $-0.13 | ||
| Q1 24 | $-0.20 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $25.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $267.0M |
| 总资产 | $11.0M | $300.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIAFOABI
| Q4 25 | $6.4M | $25.5M | ||
| Q3 25 | $7.7M | $28.5M | ||
| Q2 25 | $802.8K | $18.3M | ||
| Q1 25 | $444.7K | $10.9M | ||
| Q4 24 | $1.1M | $27.6M | ||
| Q3 24 | $756.6K | $27.2M | ||
| Q2 24 | $801.3K | $20.8M | ||
| Q1 24 | $2.5M | $19.1M |
股东权益BIAFOABI
| Q4 25 | $7.3M | $267.0M | ||
| Q3 25 | $8.9M | $277.4M | ||
| Q2 25 | $-2.1M | $262.1M | ||
| Q1 25 | $1.4M | $273.5M | ||
| Q4 24 | $2.6M | $287.6M | ||
| Q3 24 | $3.1M | $291.7M | ||
| Q2 24 | $3.4M | $294.2M | ||
| Q1 24 | $5.3M | $301.4M |
总资产BIAFOABI
| Q4 25 | $11.0M | $300.9M | ||
| Q3 25 | $11.5M | $309.7M | ||
| Q2 25 | $4.8M | $295.7M | ||
| Q1 25 | $5.5M | $306.2M | ||
| Q4 24 | $6.5M | $325.6M | ||
| Q3 24 | $6.6M | $331.6M | ||
| Q2 24 | $6.7M | $337.3M | ||
| Q1 24 | $8.0M | $352.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $-5.7M |
| 自由现金流率自由现金流/营收 | -160.7% | -67.8% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.4M | $-37.0M |
8季度趋势，按日历期对齐
经营现金流BIAFOABI
| Q4 25 | $-2.6M | $-5.7M | ||
| Q3 25 | $-2.5M | $-9.8M | ||
| Q2 25 | $-2.6M | $-5.1M | ||
| Q1 25 | $-1.6M | $-15.9M | ||
| Q4 24 | $-1.7M | $-3.9M | ||
| Q3 24 | $-1.7M | $-6.6M | ||
| Q2 24 | $-1.5M | $-12.2M | ||
| Q1 24 | $-2.3M | $-17.0M |
自由现金流BIAFOABI
| Q4 25 | $-2.6M | $-5.7M | ||
| Q3 25 | $-2.5M | $-9.9M | ||
| Q2 25 | $-2.7M | $-5.3M | ||
| Q1 25 | $-1.7M | $-16.1M | ||
| Q4 24 | $-1.7M | $-3.9M | ||
| Q3 24 | $-1.7M | $-6.7M | ||
| Q2 24 | $-1.6M | $-12.9M | ||
| Q1 24 | $-2.4M | $-18.0M |
自由现金流率BIAFOABI
| Q4 25 | -160.7% | -67.8% | ||
| Q3 25 | -171.8% | -444.2% | ||
| Q2 25 | -209.6% | -136.3% | ||
| Q1 25 | -91.3% | -387.1% | ||
| Q4 24 | -76.0% | -36.3% | ||
| Q3 24 | -73.1% | -161.3% | ||
| Q2 24 | -65.1% | -169.9% | ||
| Q1 24 | -99.2% | -472.5% |
资本支出强度BIAFOABI
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.3% | 8.1% | ||
| Q2 25 | 1.1% | 4.2% | ||
| Q1 25 | 2.7% | 5.0% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.4% | 3.6% | ||
| Q2 24 | 1.2% | 9.9% | ||
| Q1 24 | 1.7% | 24.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
